Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;78(2):241-246.
doi: 10.1007/s12020-022-03119-3. Epub 2022 Jun 25.

Influence of COVID-19 vaccines on endocrine system

Affiliations
Review

Influence of COVID-19 vaccines on endocrine system

Ying Zhao et al. Endocrine. 2022 Nov.

Abstract

The COVID-19 pandemic has posed a significant health threat globally. Timely and appropriate vaccination is a key step to reduce the morbidity and mortality from COVID-19. The clinical course of COVID-19 infection and the effects of COVID-19 vaccination are influenced by patients' health situations and involve a systemic physiological reaction. Just like an "endocrine phenotype" of COVID-19 infection, endocrine dysfunction after COVID-19 vaccination also acquired clinical concerns. In the present review, we briefly introduce the commonly available vaccines against SARS-CoV-2, summarize the influence of COVID-19 vaccines on the endocrine system, and explore the underlying pathogenic mechanisms.

Keywords: COVID-19 vaccine; Endocrine dysfunction; Side effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–436. doi: 10.1038/s41586-020-2521-4. - DOI - PMC - PubMed
    1. Kreer C, Zehner M, Weber T, Ercanoglu MS, Gieselmann L, et al. Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients. Cell. 2020;182:843–854.e812. doi: 10.1016/j.cell.2020.06.044. - DOI - PMC - PubMed
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Elrobaa IH, New KJ. COVID-19: pulmonary and extra pulmonary manifestations. Front. public health. 2021;9:711616. doi: 10.3389/fpubh.2021.711616. - DOI - PMC - PubMed
    1. Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini-review. Endocrinology. 2022;163:1–20. doi: 10.1210/endocr/bqab203. - DOI - PMC - PubMed